Candidate-gene analysis of white matter hyperintensities on neuroimaging The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters
暂无分享,去创建一个
P. Bentley | N. Rost | J. Meschia | B. Worrall | I. Cotlarciuc | Sunaina Yadav | C. Levi | Nazeeha Hasan | Theresa Tran | Pankaj Sharma
[1] Maja A. A. Binnewijzend,et al. Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease , 2013, Neurobiology of Aging.
[2] Kaitlin M. Fitzpatrick,et al. 17q25 Locus Is Associated With White Matter Hyperintensity Volume in Ischemic Stroke, But Not With Lacunar Stroke Status , 2013, Stroke.
[3] A. Kondacs,et al. Evaluation of the MTHFR A1298C Variant in Leukoaraiosis , 2012, Journal of Molecular Neuroscience.
[4] Basil Grueter,et al. Age-related cerebral white matter disease (leukoaraiosis): a review , 2011, Postgraduate Medical Journal.
[5] A. Pavlovic,et al. Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease , 2011, Clinical Neurology and Neurosurgery.
[6] P. Schofield,et al. The Genetics of White Matter Lesions , 2011, CNS neuroscience & therapeutics.
[7] M. Fornage,et al. Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.
[8] H. Soininen,et al. Changes in Vascular Risk Factors from Midlife to Late Life and White Matter Lesions: A 20-Year Follow-Up Study , 2011, Dementia and Geriatric Cognitive Disorders.
[9] Eric E. Smith,et al. White matter hyperintensity volume is increased in small vessel stroke subtypes , 2010, Neurology.
[10] André G. Uitterlinden,et al. Genetic variation in homocysteine metabolism, cognition, and white matter lesions , 2010, Neurobiology of Aging.
[11] H. Markus,et al. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[12] Eric E. Smith,et al. Determinants of white matter hyperintensity volume in patients with acute ischemic stroke. , 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[13] W. Taylor,et al. Influence of the MTHFR C677T polymorphism on magnetic resonance imaging hyperintensity volume and cognition in geriatric depression. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[14] B. Mazoyer,et al. Apolipoprotein E Genotype Is Related to Progression of White Matter Lesion Load , 2009, Stroke.
[15] C. Anderson,et al. Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History , 2009, Stroke.
[16] C. Sudlow,et al. Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects , 2009, Stroke.
[17] H. Urbach,et al. Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. , 2009, Neuro-oncology.
[18] P. Scheltens,et al. The renin-angiotensin-aldosterone system in cerebral small vessel disease , 2008, Journal of Neurology.
[19] Stephan Züchner,et al. The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[20] A. Karantanas,et al. Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[21] P. Ridker,et al. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. , 2007, The American journal of cardiology.
[22] V. Thijs,et al. Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds. , 2007, Stroke.
[23] Z. Szolnoki. Pathomechanism of leukoaraiosis , 2007, NeuroMolecular Medicine.
[24] H. Markus,et al. Polymorphisms in Genes of the Renin-Angiotensin System and Cerebral Small Vessel Disease , 2006, Cerebrovascular Diseases.
[25] V. Mok,et al. Apolipoprotein E ɛ4 allele is associated with the volume of white matter changes in patients with lacunar infarcts , 2006 .
[26] Y. W. Chen,et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy , 2006, Neurology.
[27] J. Growdon,et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. , 2006, Neurology.
[28] M. Mascalchi,et al. Alzheimer’s Disease: Role of Size and Location of White Matter Changes in Determining Cognitive Deficits , 2005, Dementia and Geriatric Cognitive Disorders.
[29] M. V. van Boxtel,et al. Associations of the Angiotensin II Type 1 Receptor A1166C and the Endothelial NO Synthase G894T Gene Polymorphisms With Silent Subcortical White Matter Lesions in Essential Hypertension , 2005, Stroke.
[30] A. Hofman,et al. ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala , 2005, Neurobiology of Aging.
[31] C. DeCarli,et al. Total Homocysteine Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study , 2005, Stroke.
[32] S. Ebrahim,et al. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? , 2005, BMJ : British Medical Journal.
[33] L. Smeeth,et al. For Personal Use. Only Reproduce with Permission from Elsevier Ltd Homocysteine and Stroke: Evidence on a Causal Link from Mendelian Randomisation , 2022 .
[34] S. Greenberg,et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage , 2004, Neurology.
[35] Charles DeCarli,et al. Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.
[36] Charles DeCarli,et al. Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.
[37] Jan Cees de Groot,et al. Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions , 2004, Stroke.
[38] A. Kondacs,et al. Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis , 2004, Acta neurologica Scandinavica.
[39] P. Sham,et al. Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease , 2004, Stroke.
[40] M. Fornage,et al. Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.
[41] K. Yoshikawa,et al. Renin-angiotensin system gene polymorphism in Japanese stroke patients , 2003 .
[42] K. Kohara,et al. MTHFR Gene Polymorphism as a Risk Factor for Silent Brain Infarcts and White Matter Lesions in the Japanese General Population: The NILS-LSA Study , 2003, Stroke.
[43] C. Dufouil,et al. Influence of education on the relationship between white matter lesions and cognition , 2003, Neurology.
[44] L. Kuller. [Risk factors for dementia in the Cardiovascular Health Study cognition study]. , 2003, Revista de neurologia.
[45] D. Wald,et al. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis , 2002, BMJ : British Medical Journal.
[46] A. Smith,et al. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. , 2002, Archives of neurology.
[47] J. Bamford,et al. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes , 2002, Journal of neurology, neurosurgery, and psychiatry.
[48] A. de la Sierra,et al. Renin-Angiotensin System Genetic Polymorphisms and Cerebral White Matter Lesions in Essential Hypertension , 2002, Hypertension.
[49] M. Senaratne,et al. Possible ethnic differences in plasma homocysteine levels associated with coronary artery disease between south asian and east asian immigrants , 2001, Clinical cardiology.
[50] F. Fazekas,et al. Angiotensinogen Polymorphism M235T, Carotid Atherosclerosis, and Small-Vessel Disease-Related Cerebral Abnormalities , 2001, Hypertension.
[51] C. Reynolds,et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. , 2001, The American journal of psychiatry.
[52] J. Guàrdia,et al. MRI and genetic correlates of cognitive function in elders with memory impairment , 2001, Neurobiology of Aging.
[53] E Auffray,et al. Longitudinal study of blood pressure and white matter hyperintensities , 2001, Neurology.
[54] F. Cambien,et al. Aldosterone synthase (CYP11B2) gene polymorphism and cerebral white matter hyperintensities , 2001, Neurology.
[55] J M Wardlaw,et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.
[56] S. Yusuf,et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.
[57] F. Fazekas,et al. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[58] H. Kawakami,et al. Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.
[59] P. Wolf,et al. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[60] E. Mori,et al. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. , 2000, Stroke.
[61] R. Doody,et al. Does APO epsilon4 correlate with MRI changes in Alzheimer's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.
[62] C. Azen,et al. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. , 1999, The American journal of clinical nutrition.
[63] D. Easton,et al. Apolipoprotein E Genetic Variation and Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.
[64] C. DeCarli,et al. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. , 1999, Stroke.
[65] Z. Janka,et al. Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population , 1998, Acta neurologica Scandinavica.
[66] G. Wilcock,et al. Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population , 1998, International journal of geriatric psychiatry.
[67] B L Miller,et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.
[68] K. Blennow,et al. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality , 1998, Journal of neurology, neurosurgery, and psychiatry.
[69] C. Broeckhoven,et al. Dutch hereditary cerebral amyloid angiopathy: Structural lesions and apolipoprotein E genotype , 1997, Annals of neurology.
[70] F. Fazekas,et al. Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates , 1996, Clinical genetics.
[71] J. Pruvo,et al. Risk factors and leukoaraiosis in stroke patients , 1996, Acta neurologica Scandinavica.
[72] S. Gauthier,et al. Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.
[73] AllanJ. Fox,et al. LEUKOARAIOSIS , 1989, The Lancet.